ATE205504T1
Peptide nucleic acids.
Abstract
A novel class of compounds, known as peptide nucleic acids, bind complementary ssDNA and RNA strands more strongly than a corresponding DNA. The peptide nucleic acids generally comprise ligands such as naturally occurring DNA bases attached to a peptide backbone through a suitable linker.
Term
Term ended
Projected expiry passed 22 May 2012, 14.3 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
192 members in 19 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 98691 | Denmark | A | |
| 98791 | Denmark | A | |
| 51092 | Denmark | A | |
| 9201219 | European Patent Office (EPO) | W |
Members192
| Document | Office | Kind | |
|---|---|---|---|
| DK98691D0 | Denmark | D0 | |
| DK98791D0 | Denmark | D0 | |
| DK51092D0 | Denmark | D0 | |
| CA2109320A1 | Canada | A1 | |
| CA2109805A1 | Canada | A1 | |
| WO9220702A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO9220703A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1880692A | Australia | A | |
| AU1884392A | Australia | A | |
| NO934122D0 | Norway | D0 | |
| FI935208A | Finland | A | |
| FI935208A7 | Finland | A7 | |
| NO934235D0 | Norway | D0 | |
| NO934122L | Norway | L | |
| NO934235L | Norway | L | |
| HU9303023D0 | Hungary | D0 | |
| EP0586474A1 | European Patent Office (EPO) | A1 | |
| EP0586618A1 | European Patent Office (EPO) | A1 | |
| JPH06506945A | Japan | A | |
| JPH06509063A | Japan | A | |
| CA2161230A1 | Canada | A1 | |
| WO9425477A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU6760494A | Australia | A | |
| WO9425477A3 | World Intellectual Property Organization (WIPO) | A3 | |
| BR9206049A | Brazil | A | |
| HUT66597A | Hungary | A | |
| CA2166461A1 | Canada | A1 | |
| CA2166462A1 | Canada | A1 | |
| WO9501369A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO9501370A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO9602558A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU666480B2 | Australia | B2 | |
| AU3196795A | Australia | A | |
| EP0699208A1 | European Patent Office (EPO) | A1 | |
| KR960701888A | Republic of Korea | A | |
| WO9611205A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3999495A | Australia | A | |
| EP0717750A1 | European Patent Office (EPO) | A1 | |
| WO9620212A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU4729796A | Australia | A | |
| US5539082A | United States of America | A | |
| WO9620212A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JPH09503198A | Japan | A | |
| EP0773950A1 | European Patent Office (EPO) | A1 | |
| EP0776331A1 | European Patent Office (EPO) | A1 | |
| US5641625A | United States of America | A | |
| EP0586618B1 | European Patent Office (EPO) | B1 | |
| AU680253B2 | Australia | B2 | |
| AT155483T | Austria | T | |
| ATE155483T1 | Austria | T1 | |
| DE69220946D1 | Germany | D1 | |
| WO9732888A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2072397A | Australia | A | |
| JPH09509435A | Japan | A | |
| EP0804456A1 | European Patent Office (EPO) | A1 | |
| ES2107552T3 | Spain | T3 | |
| DE69220946T2 | Germany | T2 | |
| CA2261566A1 | Canada | A1 | |
| WO9803542A1 | World Intellectual Property Organization (WIPO) | A1 | |
| GR3025018T3 | Greece | T3 | |
| JPH10501121A | Japan | A | |
| US5714331A | United States of America | A | |
| DK0586618T3 | Denmark | T3 | |
| AU3808197A | Australia | A | |
| US5719262A | United States of America | A | |
| JPH10503524A | Japan | A | |
| JPH10503759A | Japan | A | |
| US5736336A | United States of America | A | |
| KR0133131B1 | Republic of Korea | B1 | |
| JP2758988B2 | Japan | B2 | |
| US5766855A | United States of America | A | |
| US5773571A | United States of America | A | |
| US5786461A | United States of America | A | |
| EP0776331A4 | European Patent Office (EPO) | A4 | |
| CA2291839A1 | Canada | A1 | |
| WO9853801A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP0885238A1 | European Patent Office (EPO) | A1 | |
| AU7602198A | Australia | A | |
| EP0804456A4 | European Patent Office (EPO) | A4 | |
| KR100195290B1 | Republic of Korea | B1 | |
| JPH11507950A | Japan | A | |
| JPH11236396A | Japan | A | |
| US5977296A | United States of America | A | |
| JPH11310593A | Japan | A | |
| US5986053A | United States of America | A | |
| EP0960121A1 | European Patent Office (EPO) | A1 | |
| AU717387B2 | Australia | B2 | |
| JP2000503671A | Japan | A | |
| EP0773950A4 | European Patent Office (EPO) | A4 | |
| EP1003480A1 | European Patent Office (EPO) | A1 | |
| US6107470A | United States of America | A | |
| EP1074559A1 | European Patent Office (EPO) | A1 | |
| JP2001501975A | Japan | A | |
| US6201103B1 | United States of America | B1 | |
| IL133087D0 | Israel | D0 | |
| US6228982B1 | United States of America | B1 | |
| NZ501289A | New Zealand | A | |
| EP0586474B1 | European Patent Office (EPO) | B1 | |
| AT205504T | Austria | T | |
| ATE205504T1This record | Austria | T1 |
Showing 100 of 192
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Ceased due to non-payment of the annual feeCeasedREN | REN | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 92911165
Titles2
- German
- PEPTIDNUKLEINSÄUREN
- English
- PEPTIDE NUCLEIC ACIDS
Classification
- CPC, 13
- C07H21/00
- A61K38/00
- C07K5/06026
- C07K5/06139
- C07K7/06
- C07K7/08
- C07K14/003
- C12Q1/68
- C12Q1/6813
- C12Q1/6832
- C12Q1/6869
- A61P31/12
- A61P43/00
- IPC, 20
- A61K31 70
- A61K38 00
- A61K48 00
- A61P31 12
- A61P43 00
- C07H21 00
- C07H21 04
- C07K1 22
- C07K5 06
- C07K5 078
- C07K5 08
- C07K5 10
- C07K7 06
- C07K7 08
- C07K9 00
- C07K14 00
- C07K16 00
- C08G69 00
- C12N15 09
- C12Q1 68